Invention Application
US20150374852A1 Use of IGF-1 as a Reagent for Early Diagnosis and/or Prognosis of Alzheimer Disease
审中-公开
使用IGF-1作为早期诊断和/或阿尔茨海默病预后的试剂
- Patent Title: Use of IGF-1 as a Reagent for Early Diagnosis and/or Prognosis of Alzheimer Disease
- Patent Title (中): 使用IGF-1作为早期诊断和/或阿尔茨海默病预后的试剂
-
Application No.: US14767490Application Date: 2014-02-12
-
Publication No.: US20150374852A1Publication Date: 2015-12-31
- Inventor: Angel Trueba Saiz , Ignacio Torres Aleman , Carmen Cavada Martinez , Angel Nunez Molina
- Applicant: CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (CSIC) , UNIVERSIDAD AUTÓNOMA DE MADRID
- Applicant Address: ES Madrid
- Assignee: Consejo Superior De Investigaciones Cientificas (CSIC)
- Current Assignee: Consejo Superior De Investigaciones Cientificas (CSIC)
- Current Assignee Address: ES Madrid
- Priority: ESP201330187 20130213
- International Application: PCT/ES2014/070103 WO 20140212
- Main IPC: A61K49/00
- IPC: A61K49/00 ; A61K45/06 ; A61K38/30
Abstract:
The invention relates to the use of the insulin-like growth factor (IGF-1) as a reagent for the early diagnosis and/or prognosis of Alzheimer disease, to a kit comprising IGF-1 and a sedative, and to the use thereof in the early diagnosis and/or prognosis of Alzheimer disease.
Information query
